Investigation of the Effects of Functional Inspiratory Muscle Training in Patients With Lung Cancer

Summary

Patients' pulmonary functions and diffusion capacity worsen following lung cancer surgery. Diaphragmatic activity and lung compliance decrease due to surgery. Peripheral and respiratory muscle functions are impaired in patients with lung cancer, exercise capacity and physical activity level decreased. Patients have postural instability and balance problems. Inspiratory muscle training has increased inspiratory muscle strength in patients with lung cancer. However, there is no study investigating functional inspiratory muscle training in patients with lung cancer.

Conditions

• Lung Cancer

Interventions

DEVICE

Functional inspiratory muscle training group

Patients will be given fundamental inspiratory muscle training with the inspiratory muscle training device at 50% of the maximal inspiratory pressure 30 min/day, 3 days/week for 4 weeks online with a physiotherapist. On the other days of the week, the training will be used as a home program. In the 5th week, the functional inspiratory muscle training program will be started. Before the program begins, patients will be shown the exercises in the functional inspiratory muscle training program. Patients will be given functional inspiratory muscle training with the inspiratory muscle training device at 50% of the maximal inspiratory pressure 30 min/day, 3 days/week for 4 weeks online with a physiotherapist. On the other days of the week, fundamental inspiratory muscle training will be used as a home program. Pressure increases will be made weekly to 10 centimeters of water (cmH2O). Unsupervised training sessions will be followed by charts filled out by patients.

DEVICE

Control group

The control group will not be given any training during the 8-week period. After the study, the treatment applied to the training group will also be applied to the control group in order to ensure that the patients in the control group are not ethically deprived of rehabilitation.

Sponsors & Collaborators

• Gazi University

  lead OTHER

Principal Investigators

• Gülsüm SERTTAŞ GÜVEN, MSc. · Gazi University

• Ece BAYTOK, MSc. · Gazi University

• Muhammet SAYAN, A. Prof. Dr · Gazi University

• Ali ÇELİK, Prof. Dr. · Gazi University

• Meral BOŞNAK GÜÇLÜ, Prof. Dr. · Gazi University

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

80 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2024-05-15

Primary Completion

2026-09-15

Completion

2026-12-15

Countries

• Turkey (Türkiye)

Study Locations